New and Nonofficial Drugs 1960: An Annual Compilation of Available Information on Drugs, Including Their Therapeutic, Prophylactic and Diagnostic Status, as Evaluated by the Council on Drugs of the American Medical Association

Kautz, H. D.

doi:10.1001/jama.1960.03020170114029

JAMA

1960

DOI: 10.1001/jama.1960.03020170114029

|View full text |Cite

New and Nonofficial Drugs 1960: An Annual Compilation of Available Information on Drugs, Including Their Therapeutic, Prophylactic and Diagnostic Status, as Evaluated by the Council on Drugs of the American Medical Association

H. D. Kautz¹

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1962

1980

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy

Legha

Buzdar

Smith

et al. 1980

Cancer

View full text Add to dashboard Cite

One hundred thirty-six patients with metastatic carcinoma of the breast who received adequate trials of hormonal therapy were evaluated in order to determine the relationship of response to prior hormonal therapy and the results achieved with combination chemotherapy. Fifty-three patients had shown objective responses and 83 had failed to respond to the commonly used modes of endocrine therapy for carcinoma of the breast. Distribution of patient characteristics known to influence the response to chemotherapy and the type of chemotherapy used were similar for both groups. Of 53 hormone-responsive patients, 37 achieved either complete or partial responses for an overall response rate of 70%, not significantly different from the 67% response rate observed among patients unresponsive to hormonal therapy. The estimated medial duration of chemotherapy-induced response was 23 months for hormone-responsive patients, as compared with 13 months for the patients unresponsive to hormonal therapy (P < 0.01). Similarly, survival time was significantly prolonged among hormone-responsive patients as compared with the nonresponding patients, with estimated median survival times of 33 months and 16 months, respectively (P < 0.01). Central nervous system metastases developed in 16 (19%) of the 83 patients unresponsive to hormoinal therapy and this was significantly higher than the 6% rate (3 of 53) observed among the hormone-responsive patients (P = 0.05). Our data indicate that the nature of response to hormonal therapy in advanced breast cancer is an important prognostic factor for the results achieved with combination chemotherapy. An apparent increase in the incidence of central nervous system metastases among the hormone-unresponsive patients warrents further study.

show abstract

Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy

Legha

Buzdar

Smith

et al. 1980

Cancer

View full text Add to dashboard Cite

show abstract

The Newer Tranquilizing Drugs

Welsh

1964

Medical Clinics of North America

View full text Add to dashboard Cite

Acute Toxic Reaction to Prolonged Glutethimide Administration

Zivin¹,

Shalowitz²

1962

N Engl J Med

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

New and Nonofficial Drugs 1960: An Annual Compilation of Available Information on Drugs, Including Their Therapeutic, Prophylactic and Diagnostic Status, as Evaluated by the Council on Drugs of the American Medical Association

Cited by 3 publications

References 0 publications

Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy

Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy

The Newer Tranquilizing Drugs

Acute Toxic Reaction to Prolonged Glutethimide Administration

Contact Info

Product

Resources

About